DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Terasaki M, Hiromura M, Mori Y. et al.
Amelioration of hyperglycemia with a sodium-glucose cotransporter 2 inhibitor prevents macrophage-driven atherosclerosis through macrophage foam cell formation suppression in type 1 and type 2 diabetic mice.
PLoS One 2015;
10: e0143396
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.